cover image: New medicines and new technologies: a saving or a burden? -  - Frank R. Lichtenberg

Premium

20.500.12592/3jsrsk

New medicines and new technologies: a saving or a burden? - - Frank R. Lichtenberg

It is really based on the collective judgment of the he Pretty damning words from the mouth of the director of NICE ! HTA, as currently designed, places into conflict the short-term budgeting dilemmas of governments (elected for relatively short periods of time ) versus the ever lengthening life spans of the electorate. [...] We specially focus here on the top of the pyramid to the asthma attacks and exacerbations because most of the costs, most of the human suffering, the disability, hospitali sation and the mortality is caused by asthma attacks and exacerbations. [...] delta cost, the difference in cost between using the new technology and the , to compare the cost of using a new drug to the old drug. [...] I think theoretically, one should think of the difference in cost as: cost drug that is the first component, which means the difference in the actual cost of the pharmaceutical plus cost other medical costs the difference in productivity between using the new product and the old product. [...] The last thing that I wanted to mention is that, of course, the other variable that one needs to take account of is the threshold value of the value of a statistical life year.
Pages
20
Published in
Belgium